Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06905626 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Weight Gain Prevention in Adolescents and Young Adults

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion pushed from Mar 31, 2030 to Oct 31, 2030
    • Start date: Jun 1, 2026 to Nov 1, 2026
    • Study completion pushed from Mar 31, 2031 to Oct 31, 2031
    v5
  2. Minor Primary completion date: Nov 30, 2030 to Mar 31, 2030
    • Study completion date: Nov 30, 2032 to Mar 31, 2031
    • Start date: Dec 1, 2026 to Jun 1, 2026
    v4
  3. Notable Primary completion date: May 31, 2030 to Nov 30, 2030
    • Start date: Jan 1, 2026 to Dec 1, 2026
    • Study completion date: May 31, 2031 to Nov 30, 2032
    v3
  4. Notable Primary completion date: May 31, 2029 to May 31, 2030
    • Start date: Jun 1, 2025 to Jan 1, 2026
    • Study completion date: May 31, 2030 to May 31, 2031
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators believe they key to effective prevention of obesity is early identification of individuals at high risk of excess weight gain and proactive implementation of a comprehensive approach including lifestyle-based coaching and preventive medical management targeting the pathophysiology of dysregulated energy metabolism. In this study the investigators will take a fundamentally different approach to the science of obesity prevention by targeting the underlying biological processes driving unhealthy weight gain in adolescents/young adults (AYAs), a group that has been underrepresented in medication trials.
Trial Details
NCT Number NCT06905626
Lead Sponsor University of Minnesota
Conditions
(from sponsor)
Healthy Volunteers
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov